| A 3D printed bilayer oral solid dosage form combining metformin for prolonged and glimepiride for immediate drug delivery CI Gioumouxouzis, A Baklavaridis, OL Katsamenis, CK Markopoulou, ... European Journal of Pharmaceutical Sciences 120, 40-52, 2018 | 229 | 2018 |
| 3D printed oral solid dosage forms containing hydrochlorothiazide for controlled drug delivery CI Gioumouxouzis, OL Katsamenis, N Bouropoulos, DG Fatouros Journal of Drug Delivery Science and Technology 40, 164-171, 2017 | 173 | 2017 |
| Recent advances in pharmaceutical dosage forms and devices using additive manufacturing technologies CI Gioumouxouzis, C Karavasili, DG Fatouros Drug discovery today 24 (2), 636-643, 2019 | 145 | 2019 |
| Fabrication of an osmotic 3D printed solid dosage form for controlled release of active pharmaceutical ingredients CI Gioumouxouzis, E Tzimtzimis, OL Katsamenis, A Dourou, ... European Journal of Pharmaceutical Sciences 143, 105176, 2020 | 93 | 2020 |
| Controlled release of 5-fluorouracil from alginate beads encapsulated in 3D printed pH-responsive solid dosage forms CI Gioumouxouzis, AT Chatzitaki, C Karavasili, OL Katsamenis, D Tzetzis, ... Aaps Pharmscitech 19, 3362-3375, 2018 | 78 | 2018 |
| The advent of a new era in digital healthcare: a role for 3D printing technologies in drug manufacturing? II Andreadis, CI Gioumouxouzis, GK Eleftheriadis, DG Fatouros Pharmaceutics 14 (3), 609, 2022 | 64 | 2022 |
| Mucosal drug delivery and 3D printing technologies: A focus on special patient populations C Karavasili, GK Eleftheriadis, C Gioumouxouzis, EG Andriotis, ... Advanced Drug Delivery Reviews 176, 113858, 2021 | 54 | 2021 |
| Quality control evaluation of paediatric chocolate-based dosage forms: 3D printing vs mold-casting method K Chachlioutaki, C Karavasili, EE Mavrokefalou, CI Gioumouxouzis, ... International journal of pharmaceutics 624, 121991, 2022 | 33 | 2022 |
| Negative electrospray ionization mode in mass spectrometry: a new perspective via modeling CI Gioumouxouzis, MG Kouskoura, CK Markopoulou Journal of Chromatography B 998, 97-105, 2015 | 21 | 2015 |
| A floating 3D printed polypill formulation for the coadministration and sustained release of antihypertensive drugs P Zgouro, OL Katsamenis, T Moschakis, GK Eleftheriadis, AS Kyriakidis, ... International Journal of Pharmaceutics 655, 124058, 2024 | 9 | 2024 |
| X‐ray microfocus computed tomography: a powerful tool for structural and functional characterisation of 3D printed dosage forms CI Gioumouxouzis, OL Katsamenis, DG Fatouros Journal of Microscopy 277 (3), 135-139, 2020 | 9 | 2020 |
| Small patients, big challenges: navigating pediatric drug manipulations to prevent medication errors-a comprehensive review K Chachlioutaki, C Gioumouxouzis, C Karavasili, DG Fatouros Expert Opinion on Drug Delivery 20 (11), 1489-1509, 2023 | 7 | 2023 |
| Emerging 3D printing technologies to develop novel pharmaceutical formulations CI Gioumouxouzis1, GK Eleftheriadis1, DG Fatouros1 3D and 4D Printing in Biomedical Applications: Process Engineering and …, 2019 | 6 | 2019 |
| Analytical QbD for the optimization of a multimode HPLC method for the investigation of hydrochlorothiazide, diltiazem and propranolol release from 3D printed formulation IM Samara, M Ntorkou, CI Gioumouxouzis, C Karavasili, PD Tzanavaras, ... Journal of Pharmaceutical and Biomedical Analysis 248, 116324, 2024 | 3 | 2024 |
| Correction: Andreadis et al. The Advent of a New Era in Digital Healthcare: A Role for 3D Printing Technologies in Drug Manufacturing? Pharmaceutics 2022, 14, 609 II Andreadis, CI Gioumouxouzis, GK Eleftheriadis, DG Fatouros Pharmaceutics 14 (12), 2782, 2022 | | 2022 |
| Short Lecture “New 3D-printed oral dosage forms” C Karavasili, C Gioumouxouzis, G Eleftheriadis, D Fatouros Planta Medica 88 (15), SL-FOR04, 2022 | | 2022 |
| 3PC-068 3D printing of elaborate pharmaceutical formulations for personalised therapy C Gioumouxouzis, O Katsamenis, D Fatouros Eur J Hosp Pharm 26 (Suppl 1), A67-A68, 2019 | | 2019 |
| FABRICATION OF INNOVATIVE DOSAGE FORMS BY MEANS OF 2D/3D PRINTING CI Gioumouxouzis, EG Andriotis, DG Fatouros | | |
Dimitris FatourosProfessor, Aristotle University of ThessalonikiAdresse e-mail validée de pharm.auth.gr